JawaPos.com – Although it is claimed that monkeypox cases around the world have declined in a number of countries, including the United States and European countries, vaccination options have begun to be prepared as a precautionary measure. The Executive Board of the Indonesian Doctors Association (PB IDI) provides recommendations for the type of vaccine that will be used in Indonesia.
Head of Task Force Monkeypox PB IDI, Dr. Hanny Nilasari said the Modified Vaccinia Ankaria-Bavarian Nodic (MVA-BN) vaccine can be given to patients with monkeypox.monkeypox) in the country. The vaccine considers its efficacy and safety. According to him, the vaccine has passed clinical trials and has been widely used.
“This vaccine does not need to be tested again in Indonesia. Because previously in the cases of endemic countries in Africa, this vaccine has been used, because there are many reports in non-endemic countries, so it is used in our country,” he said. said in a virtual statement on Wednesday (9/21).
Furthermore, MVA-BN was chosen because it can be sold immunocompromised (people with weak immunity), pregnant women and children. Even so, Dr. Hanny pointed out that this vaccine does not cure 100%, but it minimizes complications in monkeypox patients.
“Vaccination does not eliminate 100% of the virus, but it can reduce complications such as central nervous system disorders or nerve infections,” he explained.
So who is eligible for the vaccine?
At least vaccinate monkeypox in three priority groups. First, health professionals who conduct direct examinations.
Secondly, people who are in contact with the sick. They must be vaccinated so that the symptoms are not too severe.
Third, they are people at risk of having multiple partners or multipartners and homosexual groups. “Because of all the people affected by monkeypox, 90% of them are LGBT people. So they are at risk and deserve to be vaccinated, “she said.
–
Publisher: Banu Adikara
Reporter: Marieska Harya Virdhani
–
